Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

The combination of encorafenib and binimetinib caused few skin issues.

The combination treatment showed a higher response rate but no significant survival benefits.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Sorafenib can cause a unique skin reaction.

Bortezomib chemotherapy can cause temporary skin rashes.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Promising cancer treatments were found, but the manufacturer closed.

Baricitinib was effective in treating both early and late onset alopecia areata.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.